CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Revenues
Total revenues	$ 11,041,051	$ 8,598,776	$ 21,184,341	$ 16,819,415
Cost of revenues	5,425,311	3,900,965	10,520,932	7,123,355
Gross profit	5,615,740	4,697,811	10,663,409	9,696,060
Operating expenses
Selling, general and administrative	5,304,625	4,255,976	10,250,075	8,896,888
Depreciation and amortization	958,001	713,180	1,803,017	1,392,351
Total operating expenses	6,262,626	4,969,156	12,053,092	10,289,239
Loss from operations	(646,886)	(271,345)	(1,389,683)	(593,179)
Other income
Interest income, net	600,867	70,227	1,185,064	84,563
Loss before income tax provision	(46,019)	(201,118)	(204,619)	(508,616)
Income tax provision	58,137	26,916	59,667	28,813
Net loss	$ (104,156)	$ (228,034)	$ (264,286)	$ (537,429)
Basic	$ (0.00)	$ (0.00)	$ (0.01)	$ (0.01)
Diluted	$ (0.00)	$ (0.00)	$ (0.01)	$ (0.01)
Weighted average common shares
Basic	52,259,002	51,993,031	52,330,829	51,906,335
Diluted	52,259,002	51,993,031	52,330,829	51,906,335
Plasma Industry [Member]
Revenues
Total revenues	$ 10,014,461	$ 7,806,201	$ 19,374,528	$ 15,200,565
Pharmaceutical Industry [Member]
Revenues
Total revenues	729,236	773,311	1,318,798	1,579,879
Other Revenue [Member]
Revenues
Total revenues	$ 297,354	$ 19,264	$ 491,015	$ 38,971